Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heimfeld

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|June 1, 1994
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord bloodS Z Zhou, S Cooper, L Y Kang, et al.
Blood Cells|January 1, 1994
Isolation and ex vivo expansion of CD34+ cells from cord blood using dextran sedimentation and avidin column selectionS Heimfeld, D F Kalamasz, B L Fogarty, et al.
Bone Marrow Transplantation|June 13, 2000
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionJ Yu, W Leisenring, W Fritschle, et al.
Blood|November 1, 1994
Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vectorC von Kalle, H P Kiem, S Goehle, et al.
Journal of Hematotherapy|January 1, 1994
Transplantation of CD34+ hematopoietic progenitor cellsE J Shpall, R B Jones, S I Bearman, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractionsD Petsche, L Hami, M Purdy, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Positive selection of CD34+ hematopoietic progenitor cells for transplantationE J Shpall, R B Jones, S I Bearman, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cellsF Shapiro, T J Yao, C Moskowitz, et al.
Progress in Clinical and Biological Research|January 1, 1992
Transplantation of stem cells enriched by immunoadsorptionR J Berenson, W I Bensinger, D F Kalamasz, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|June 1, 1994
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord bloodS Z Zhou, S Cooper, L Y Kang, et al.
Blood Cells|January 1, 1994
Isolation and ex vivo expansion of CD34+ cells from cord blood using dextran sedimentation and avidin column selectionS Heimfeld, D F Kalamasz, B L Fogarty, et al.
Bone Marrow Transplantation|June 13, 2000
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionJ Yu, W Leisenring, W Fritschle, et al.
Blood|November 1, 1994
Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vectorC von Kalle, H P Kiem, S Goehle, et al.
Journal of Hematotherapy|January 1, 1994
Transplantation of CD34+ hematopoietic progenitor cellsE J Shpall, R B Jones, S I Bearman, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractionsD Petsche, L Hami, M Purdy, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Positive selection of CD34+ hematopoietic progenitor cells for transplantationE J Shpall, R B Jones, S I Bearman, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cellsF Shapiro, T J Yao, C Moskowitz, et al.
Progress in Clinical and Biological Research|January 1, 1992
Transplantation of stem cells enriched by immunoadsorptionR J Berenson, W I Bensinger, D F Kalamasz, et al.
Pageof 8